186 related articles for article (PubMed ID: 37436451)
1. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
3. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Guo HL; Zheng X; Cheng MQ; Zeng D; Huang H; Xie XY; Lu MD; Kuang M; Wang W; Xian MF; Chen LD
J Ultrasound Med; 2022 May; 41(5):1213-1225. PubMed ID: 34423864
[TBL] [Abstract][Full Text] [Related]
5. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
7. A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Wang LF; Guan X; Shen YT; Zhou BY; Sun YK; Li XL; Yin HH; Lu D; Ye X; Hu XY; Yang DH; Xia HS; Wang X; Lu Q; Han H; Xu HX; Zhao CK;
Abdom Radiol (NY); 2024 Feb; 49(2):458-470. PubMed ID: 38225379
[TBL] [Abstract][Full Text] [Related]
8. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
9. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
10. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
Ainora ME; Cerrito L; Liguori A; Mignini I; De Luca A; Galasso L; Garcovich M; Riccardi L; Ponziani F; Santopaolo F; Pompili M; Gasbarrini A; Zocco MA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239893
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
[TBL] [Abstract][Full Text] [Related]
13. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
15. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
[TBL] [Abstract][Full Text] [Related]
18. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria.
Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538
[No Abstract] [Full Text] [Related]
19. Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
Chen LD; Ruan SM; Lin Y; Liang JY; Shen SL; Hu HT; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
Eur Radiol; 2019 Aug; 29(8):4249-4257. PubMed ID: 30569182
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma.
Wen R; Lin P; Wu Y; Yin H; Huang W; Guo D; Peng Y; Liu D; He Y; Yang H
Eur J Radiol; 2022 Sep; 154():110415. PubMed ID: 35738166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
